You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 7,964,202


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,964,202 protect, and when does it expire?

Patent 7,964,202 protects EPIDUO and is included in one NDA.

This patent has thirty-three patent family members in twenty-two countries.

Summary for Patent: 7,964,202
Title:Method for treatment of common acne
Abstract: Dermatological/cosmetic compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise, in a physiologically acceptable medium, (i) at least one dispersed retinoid, (ii) dispersed benzoyl peroxide, in free or encapsulated form, and (iii) at least one pH-independent gelling agent, said dermatological/cosmetic composition having physical stability without loss of viscosity over time at a temperature ranging from 4.degree. C. to 40.degree. C., said dermatological/cosmetic composition having a stable flow threshold over time as measured by viscosity measurements for rheograms which measure a shear stress .tau. for a given rate gradient .gamma. and which measure a rate gradient .gamma. for a given shear stress .tau., the yield value (.tau.0) being extrapolated visually or by calculation.
Inventor(s): Orsoni; Sandrine (Mandelieu, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma Research & Development, S.N.C. (FR)
Application Number:12/076,859
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,964,202

Introduction

United States Patent 7,964,202, titled "Method for treatment of common acne," is a patent that outlines a specific method and composition for treating acne. To delve into the scope and claims of this patent, it is essential to analyze its various components, including the background, summary, detailed description, and the claims themselves.

Background of the Patent

The patent US7964202B2 addresses the treatment of common acne, a widespread skin condition characterized by the occurrence of comedones (blackheads and whiteheads), papules, pustules, and sometimes cysts and nodules. The background section of the patent discusses the existing treatments for acne, including the use of benzoyl peroxide, retinoids, and other dermatological compositions. It highlights the need for more effective and less irritating treatments[4].

Summary of the Invention

The summary section provides an overview of the invention, which involves a method for treating acne using specific dermatological or cosmetic compositions. These compositions typically include a combination of active ingredients such as benzoyl peroxide and retinoids, along with other components like isopentadecane and 2-methyl-pentadecane. The method aims to prevent or treat cell differentiation, proliferation, and keratinization disorders associated with acne[4].

Detailed Description of the Invention

The detailed description section elaborates on the components and the method of the invention. It includes:

Active Ingredients

  • Benzoyl Peroxide: Known for its antibacterial properties and its ability to reduce the blockage of pores.
  • Retinoids: Derivatives of vitamin A that help in preventing the formation of comedones and reducing inflammation[4].

Other Components

  • Isopentadecane: A natural product used to enhance the stability and efficacy of the composition.
  • 2-Methyl-Pentadecane: Another component that contributes to the overall effectiveness of the treatment[4].

Method of Treatment

The method involves applying the composition to the affected skin area, typically once or twice a day. The composition can be in various forms such as gels, creams, or lotions, depending on the patient's skin type and the severity of the acne[4].

Claims of the Patent

The claims section is crucial as it defines the scope of the patent. Here are some key claims:

Independent Claims

  • Claim 1: A method for treating acne, comprising applying a composition to the skin, where the composition includes benzoyl peroxide and a retinoid.
  • Claim 5: The method of claim 1, where the composition further includes isopentadecane and 2-methyl-pentadecane[4].

Dependent Claims

  • Claim 2: The method of claim 1, where the benzoyl peroxide is present in a concentration of about 2.5% to about 10%.
  • Claim 3: The method of claim 1, where the retinoid is adapalene[4].

Patent Scope and Breadth

The scope of the patent is defined by the claims, which determine what is protected under the patent. In this case, the patent protects a specific method of treating acne using a combination of benzoyl peroxide and retinoids, along with other specified components.

Metrics for Measuring Patent Scope

Research on patent scope often uses metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For example, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Prior Art and Citation Data

The patent cites prior art related to acne treatments, including compositions and methods involving benzoyl peroxide and retinoids. The Common Citation Document (CCD) application, which consolidates prior art cited by participating IP offices, would be useful in understanding the global citation landscape for this patent[1].

Legal Status and Expiration

The legal status of the patent indicates whether it is still in force or has expired. As of the current date, the patent US7964202B2 has expired, meaning that the protected method and composition are now in the public domain[4].

Practical Implications

The expiration of this patent allows other companies and researchers to use the described method and composition without infringing on the original patent. This can lead to more widespread availability of effective acne treatments and potentially lower costs for consumers.

Conclusion

United States Patent 7,964,202 provides a detailed method for treating common acne using a specific combination of active ingredients. Understanding the scope and claims of this patent is crucial for anyone looking to develop or use similar treatments. The expiration of the patent opens up opportunities for further innovation and accessibility in acne treatment.

Key Takeaways

  • Method and Composition: The patent describes a method for treating acne using a composition that includes benzoyl peroxide and retinoids.
  • Active Ingredients: Key components include benzoyl peroxide, retinoids, isopentadecane, and 2-methyl-pentadecane.
  • Claims: The patent claims define the scope of protection, including specific concentrations and forms of the composition.
  • Patent Scope: Metrics like independent claim length and count can measure the breadth and clarity of the patent.
  • Legal Status: The patent has expired, making the method and composition public domain.

FAQs

Q: What is the main focus of United States Patent 7,964,202? A: The main focus is a method for treating common acne using a specific composition that includes benzoyl peroxide and retinoids.

Q: What are the key active ingredients in the composition described in the patent? A: The key active ingredients are benzoyl peroxide, retinoids, isopentadecane, and 2-methyl-pentadecane.

Q: How do the claims in the patent define its scope? A: The claims define the specific method and composition protected under the patent, including concentrations and forms of the active ingredients.

Q: What metrics can be used to measure the scope of a patent? A: Metrics such as independent claim length and independent claim count can be used to measure the scope and clarity of patent claims.

Q: What is the current legal status of United States Patent 7,964,202? A: The patent has expired, making the described method and composition part of the public domain.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Patents - US7964202B2: https://patents.google.com/patent/US7964202B2/en
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,964,202

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes 7,964,202 ⤷  Subscribe Y TREATMENT OF ACNE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,964,202

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France01 16747Dec 21, 2001

International Family Members for US Patent 7,964,202

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1458369 ⤷  Subscribe CA 2008 00029 Denmark ⤷  Subscribe
European Patent Office 1458369 ⤷  Subscribe 08C0024 France ⤷  Subscribe
European Patent Office 1458369 ⤷  Subscribe SPC/GB10/005 United Kingdom ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.